GlassScriptPhysician profile
Raymond M Thomas
NPI 1811034275
$664.02
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.52 · 2020: $95.17 · 2021: $150 · 2022: $77.15 · 2023: $57.31 · 2024: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $173.06 | 2019-2023 | Rinvoq |
| Pfizer INC. | $130.28 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.03 | 2020-2022 | |
| Erbe USA INC | $55.00 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.43 | 2021-2024 | Eohilia, Entyvio |
| Regeneron Healthcare Solutions, INC. | $43.99 | 2022 | |
| Celgene Corporation | $35.35 | 2021-2022 | |
| Ardelyx, INC. | $22.67 | 2024 | Ibsrela |
| Janssen Biotech, INC. | $18.60 | 2024 | Tremfya |
| Phathom Pharmaceuticals, INC. | $17.76 | 2024 | Voquezna |
| Ferring Pharmaceuticals INC. | $13.93 | 2021 | |
| Merit Medical Systems INC | $3.92 | 2024 | Elation Balloon Dilator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.